Accuray Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 4.52
Dividend & YieldN/A$ (N/A)
Beta 1.65
Market capitalization 196M
Operating cash flow 6.25M
ESG Scores unknown

Company description

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

Sector: Healthcare - Industry: Medical Devices

Financial Ratios
Quick Ratio1.18
Working Capital-0.04
Return On Equity-0.09
Debt To Equity2.47
Fixed Asset Ratio0
Fixed Interest Cover1.32

Financial data

Financial Statements

Cashflow Statement 2019-06-30 2020-06-30 2021-06-30 2022-06-30
Change To Liabilities 15.27M -2.86M -5.3M 11.47M
Total Cashflows From Investing Activities -4.31M -3.73M -2.4M -4.72M
Net Borrowings 24.55M 24.45M -17.41M -19M
Total Cash From Financing Activities 28.47M 26.7M -28.8M -15.37M
Change To Operating Activities -1.66M -14.87M 6.18M 1.31M
Issuance Of Stock 3.93M 2.45M 3.03M 3.89M
Net Income -16.43M 3.83M -6.31M -5.35M
Change In Cash -5.36M 21.73M 8.29M -28.05M
Effect Of Exchange Rate 124k 234k 982k -5.56M
Total Cash From Operating Activities -29.64M -1.47M 38.51M -2.4M
Depreciation 10.49M 7.54M 13.58M 14.76M
Change To Account Receivables -46.16M 19.03M 5.24M -12.52M
Other Cashflows From Financing Activities
Change To Netincome 18.12M 3.53M 17.2M 9.97M
Capital Expenditures -4.31M -3.56M -2.32M -4.72M

Income Statement 2019-06-30 2020-06-30 2021-06-30 2022-06-30
Research Development 56.49M 49.78M 52.73M 57.75M
Income Before Tax -14.34M 5.69M -4.56M -2M
Net Income -16.43M 3.83M -6.31M -5.35M
Selling General Administrative 105.58M 87.4M 84.54M 94.06M
Gross Profit 162.65M 149.72M 159.51M 159.96M
Ebit 583k 12.54M 22.23M 8.15M
Operating Income 583k 12.54M 22.23M 8.15M
Interest Expense -15.08M -18.08M -16.89M -8.13M
Income Tax Expense 2.09M 1.86M 1.75M 3.35M
Total Revenue 418.79M 382.93M 396.29M 429.91M
Cost Of Revenue 256.13M 233.21M 236.78M 269.95M
Total Other Income ExpenseNet -14.93M -6.85M -26.79M -10.15M
Net Income From Continuing Ops -16.43M 3.83M -6.31M -5.35M
Net Income Applicable To Common Shares -16.43M 3.83M -6.31M -5.35M

Balance Sheet Statement 2019-06-30 2020-06-30 2021-06-30 2022-06-30
Total Liabilities 388.31M 427.29M 411.26M 419.66M
Total Stockholder Equity 49.87M 63.63M 68.84M 53.19M
Other Current Liabilities 98.73M 105.78M 106.6M 100.67M
Total Assets 438.18M 490.93M 480.1M 472.85M
Common Stock 89k 91k 91k 94k
Other Current Assets 10.36M 3.71M 3.57M 1.66M
Retained Earnings -485.54M -481.71M -488.02M -492.52M
Treasury Stock -10k -484k 2.09M 2.41M
Cash 76.8M 107.58M 116.37M 88.74M
Total Current Liabilities 192.18M 182.27M 192.36M 208.86M
Other Stockholder Equity -10k -484k 2.09M 2.41M
Property, Plant, and Equipment 17.12M 44M 34.85M 29.48M
Total Current Assets 344.07M 357.49M 352.77M 350.89M
Net Tangible Assets -8.58M 5.25M 10.45M -4.9M
Net Receivables 112.25M 91.09M 85.87M 94.94M
Accounts Payable 29.56M 23.13M 19.47M 31.34M


Insider Transactions

Here are the insider transactions of stock shares related to Accuray Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
WINTER SUZANNE CSale at price 2.01 per share.D2022-11-01President38.02k
CHEW JESSESale at price 2.01 per share.D2022-11-01General Counsel6.59k
SPINE PATRICKSale at price 2.01 per share.D2022-11-01Officer5.51k
PERVAIZ ALISale at price 2.01 per share.D2022-11-01Chief Financial Officer13.2k
WINTER SUZANNE CSale at price 2.10 per share.D2022-10-03President17.06k
CHEW JESSESale at price 2.10 per share.D2022-10-03General Counsel8.99k
SPINE PATRICKSale at price 2.10 per share.D2022-10-03Officer5.84k
HOGE MICHAELSale at price 2.10 per share.D2022-10-03Officer8.32k
GREEN BRANDON WSale at price 2.38 per share.D2022-09-01Chief Financial Officer10.37k
PERVAIZ ALISale at price 2.38 per share.D2022-09-01Chief Financial Officer8.07k
PALOMBA FRANCO NStock Award(Grant) at price 0.00 per share.D2022-06-30Officer173.47k
WINTER SUZANNE CStock Award(Grant) at price 0.00 per share.D2022-06-30President127.55k
CHALKE SANDEEPStock Award(Grant) at price 0.00 per share.D2022-05-31Officer312.5k
PERVAIZ ALIStock Award(Grant) at price 0.00 per share.D2022-05-31Chief Financial Officer24.04k
SPINE PATRICKSale at price 2.65 per share.D2022-05-04Officer1.56k
HOGE MICHAELSale at price 3.43 per share.D2022-03-01Divisional Officer11.65k
WINTER SUZANNE CPurchase at price 3.53 per share.D2022-01-31President11.24k
WINTER SUZANNE CPurchase at price 3.53 per share.D2022-01-31President761
GREEN BRANDON WStock Award(Grant) at price 0.00 per share.D2021-12-31Chief Financial Officer31.45k
WINTER SUZANNE CSale at price 4.59 per share.D2021-12-02President6.75k
CHEW JESSESale at price 4.59 per share.D2021-12-02General Counsel6.13k
SPINE PATRICKSale at price 4.59 per share.D2021-12-02Officer5.31k
HOGE MICHAELSale at price 4.59 per share.D2021-12-02Officer5.67k
WHITTERS JOSEPH EStock Award(Grant) at price 4.81 per share.D2021-11-30Director31.18k
DA VILA ELIZABETH HStock Award(Grant) at price 4.81 per share.D2021-11-30Director31.18k
HINDMAN JAMES MStock Award(Grant) at price 4.81 per share.D2021-11-30Director31.18k
HUSS BEVERLY AStock Award(Grant) at price 4.81 per share.D2021-11-30Unknown31.18k
PETTINGILL RICHARD RStock Award(Grant) at price 4.81 per share.D2021-11-30Director31.18k
LE GRAND ANNE BRYCEStock Award(Grant) at price 4.81 per share.D2021-11-30Director31.18k
SCOTT BYRON CStock Award(Grant) at price 4.81 per share.D2021-11-30Director31.18k
NISHIMURA MIKAStock Award(Grant) at price 4.81 per share.D2021-11-30Unknown31.18k
SCOTT BYRON CPurchase at price 5.45 per share.D2021-11-08Director9k
WINTER SUZANNE CSale at price 5.23 per share.D2021-11-02President23.44k
CHEW JESSESale at price 5.23 per share.D2021-11-02General Counsel8.34k
SPINE PATRICKSale at price 5.23 per share.D2021-11-02Officer5.49k
GREEN BRANDON WStock Award(Grant) at price 0.00 per share.D2021-10-29Chief Financial Officer30.06k
GREEN BRANDON WSale at price 3.95 per share.D2021-10-01Chief Financial Officer8.76k
LEVINE JOSHUA HSale at price 3.96 per share.D2021-09-30Chief Executive Officer15.74k
LEVINE JOSHUA HSale at price 3.96 per share.D2021-09-30Chief Executive Officer15.74k
WINTER SUZANNE CStock Award(Grant) at price 0.00 per share.D2021-09-30President253.16k
CHEW JESSEStock Award(Grant) at price 0.00 per share.D2021-09-30General Counsel151.9k
SPINE PATRICKStock Award(Grant) at price 0.00 per share.D2021-09-30Officer113.92k
HOGE MICHAELStock Award(Grant) at price 0.00 per share.D2021-09-30Officer151.9k
LEVINE JOSHUA HStock Award(Grant) at price 0.00 per share.D2021-09-29Chief Executive Officer501k
NISHIMURA MIKAStock Award(Grant) at price 4.07 per share.D2021-08-31Director9.21k
LEVINE JOSHUA HPurchase at price 3.62 - 3.63 per share.D2021-08-18Chief Executive Officer15k
SCOTT BYRON CPurchase at price 3.65 per share.D2021-08-18Director10k
WHITTERS JOSEPH EPurchase at price 3.64 per share.D2021-08-16Director17.5k
SPINE PATRICKSale at price 4.74 per share.D2021-05-03Officer1.42k
HOGE MICHAELSale at price 5.52 per share.D2021-03-02Officer11.27k
SCOTT BYRON CStock Award(Grant) at price 0.00 per share.D2021-02-12Director20.38k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Accuray Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Accuray Inc

Here is the result of two systematic investment strategies applied to Accuray Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Accuray Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Accuray Inc:

Accuray Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 75.12% on the backtest period.

Performance at glance

Performance

75.12 %

Latent gain

1313.98 $

Invested capital

1749.08 $

Annualized return

18.32 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Accuray Inc

This is the result of two momentum investment strategies applied to Accuray Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Accuray Inc

The following chart shows all the entries opened by the momentum investment system on Accuray Inc:

Accuray Inc momentum entries
  • The first momentum investment strategy would give 72.89% of return on Accuray Inc. That represents 3644.76$ of latent gain with 5000.25$ of employed capital.
  • The second momentum investment strategy would give 79.42% of return on Accuray Inc. That represents 2778.76$ of latent gain with 3498.83$ of employed capital.
Performance at glance (1Q Momentum)

Performance

72.89 %

Latent gain

3644.76 $

Invested capital

5000.25 $

Annualized return

25.48 %
Performance at glance (2Q Momentum)

Performance

79.42 %

Latent gain

2778.76 $

Invested capital

3498.83 $

Annualized return

21.94 %

Momentum equity curve on Accuray Inc

The following chart shows the equity curve of the two momentum strategies applied to Accuray Inc:

Accuray Inc momentum equity

Note: the dividends potentially given by Accuray Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Accuray Inc

The following chart shows the employed capital evolution of the two momentum strategies on Accuray Inc since the beginning:

Accuray Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Accuray Inc

Buy the dip entry openings on Accuray Inc

Accuray Inc

The performance achieved by the robo-advisor on Accuray Inc is 53.5%. That represents 666.73$ of latent gain with 1246.28$ of employed capital. The following chart shows Accuray Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Accuray Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

53.5 %

Latent gain

666.73 $

Invested capital

1246.28 $

Annualized return

25.48 %

Equity curve of the strategy applied to Accuray Inc

The following chart shows the result of the investment strategy applied to Accuray Inc:

Accuray Inc

Note: the dividends potentially given by Accuray Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Accuray Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Accuray Inc:

Accuray Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Accuray Inc

In this section, I will compare the three previous investment strategies applied to Accuray Inc.

Equity curve comparison on Accuray Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Accuray Inc investment strategy comparison

Employed capital comparison on Accuray Inc

Accuray Inc investment comparison

Performance comparison on Accuray Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 75.12% 1313.98$ 1749.08$ 18.32%
Momentum 1 quarter 72.89% 3644.76$ 5000.25$ 18.88%
Momentum 2 quarters 79.42% 2778.76$ 3498.83$ 21.94%
Non-directional 53.5% 666.73$ 1246.28$ 25.48%
Annualized return comparison

Automatic investment

18.32 %

Momentum 1Q

21.94 %

Momentum 2Q

21.94 %

Non-directional

25.48 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Accuray Inc:


Company information

Company name Accuray Inc
Country United States
City Sunnyvale
Address 1310 Chesapeake Terrace
Phone 408 716 4600
Website www.accuray.com
FullTime employees 1044
Industry Medical Devices
Sector Healthcare
Exchange XNAS
Ticker ARAY
Market www.nasdaq.com

Accuray Inc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown